HEXO TO WIND DOWN OPERATIONS AT BRANTFORD FACILITYFrom page 9 of MD&A released 29 Oct 21 - read it, and expand your knowledge on your investment.
HEXO’s Brantford, Ontario facility is currently serving as a strain development site (with additional cultivation capability) facility, featuring 14,000 sq. ft. of indoor growing space on 1 acre of land. The facility was designed and engineered to permit pharmaceutical-quality management standards utilized by Canada’s pharmaceutical manufacturers to be used in the production of cannabis in all acceptable forms. The facility is fully licensed by Health Canada (Standard Cultivation, Standard Processing and Sale for Medical Purposes (current license effective December 6, 2019 and expiring December 6, 2022)). Subsequent to July 31, 2021, management has decided to wind down operations at the R&D facility and relocate this activity to the Masson campus.